Literature DB >> 27933717

Mass Cytometry Analytical Approaches Reveal Cytokine-Induced Changes in Natural Killer Cells.

Elena Vendrame1, Julia Fukuyama2, Dara M Strauss-Albee3, Susan Holmes2, Catherine A Blish1,3.   

Abstract

BACKGROUND: Natural killer (NK) cells have antiviral and antitumor activity that could be harnessed for the treatment of infections and malignancies. To maintain cell viability and enhance antiviral and antitumor effects, NK cells are frequently treated with cytokines. Here they performed an extensive assessment of the effects of cytokines on the phenotype and function of human NK cells.
METHODS: They used cytometry by time-of-flight (CyTOF) to evaluate NK cell repertoire changes after stimulation with interleukin (IL)-2, IL-15 or a combination of IL-12/IL-15/IL-18. To analyze the high dimensional CyTOF data, they used several statistical and visualization tools, including viSNE (Visualization of t-Distributed Stochastic Neighbor Embedding), Citrus (Cluster identification, characterization, and regression), correspondence analysis, and the Friedman-Rafsky test.
RESULTS: All three treatments (IL-2, IL-15, and IL-12/IL-15/IL-18) increase expression of CD56 and CD69. The effects of treatment with IL-2 and IL-15 are nearly indistinguishable and characterized principally by increased expression of surface markers including CD56, NKp30, NKp44, and increased expression of functional markers, such as perforin, granzyme B, and MIP-1β. The combination of IL-12/IL-15/IL-18 induces a profound shift in the repertoire structure, decreasing expression of CD16, CD57, CD8, NKp30, NKp46, and NKG2D, and dramatically increasing expression of IFN-γ.
CONCLUSIONS: CyTOF provides insights into the effects of cytokines on the phenotype and function of NK cells, which could inform future research efforts and approaches to NK cell immunotherapy. There are several analytical approaches to CyTOF data, and the appropriate method should be carefully selected based on which aspect of the dataset is being explored.
© 2016 International Clinical Cytometry Society. © 2016 International Clinical Cytometry Society.

Entities:  

Keywords:  IL-15; IL-2; cytokines; mass cytometry; memory-like natural killer cells; natural killer cells

Mesh:

Substances:

Year:  2017        PMID: 27933717      PMCID: PMC5266600          DOI: 10.1002/cyto.b.21500

Source DB:  PubMed          Journal:  Cytometry B Clin Cytom        ISSN: 1552-4949            Impact factor:   3.058


  35 in total

1.  Cytokine-induced memory-like natural killer cells.

Authors:  Megan A Cooper; Julie M Elliott; Peter A Keyel; Liping Yang; Javier A Carrero; Wayne M Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-30       Impact factor: 11.205

2.  Cytokine activation induces human memory-like NK cells.

Authors:  Rizwan Romee; Stephanie E Schneider; Jeffrey W Leong; Julie M Chase; Catherine R Keppel; Ryan P Sullivan; Megan A Cooper; Todd A Fehniger
Journal:  Blood       Date:  2012-09-14       Impact factor: 22.113

Review 3.  Interleukin 15: A key cytokine for immunotherapy.

Authors:  Manoj Patidar; Naveen Yadav; Sarat K Dalai
Journal:  Cytokine Growth Factor Rev       Date:  2016-06-07       Impact factor: 7.638

4.  Imprint of human cytomegalovirus infection on the NK cell receptor repertoire.

Authors:  Mónica Gumá; Ana Angulo; Carlos Vilches; Natalia Gómez-Lozano; Núria Malats; Miguel López-Botet
Journal:  Blood       Date:  2004-08-10       Impact factor: 22.113

5.  Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance.

Authors:  Hisataka Kobayashi; Sigrid Dubois; Noriko Sato; Helen Sabzevari; Yoshio Sakai; Thomas A Waldmann; Yutaka Tagaya
Journal:  Blood       Date:  2004-09-14       Impact factor: 22.113

Review 6.  Tricking the balance: NK cells in anti-cancer immunity.

Authors:  Jens Pahl; Adelheid Cerwenka
Journal:  Immunobiology       Date:  2015-07-26       Impact factor: 3.144

7.  Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses.

Authors:  Silke Paust; Harvinder S Gill; Bao-Zhong Wang; Michael P Flynn; E Ashley Moseman; Balimkiz Senman; Marian Szczepanik; Amalio Telenti; Philip W Askenase; Richard W Compans; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2010-10-24       Impact factor: 25.606

8.  Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE.

Authors:  Peng Qiu; Erin F Simonds; Sean C Bendall; Kenneth D Gibbs; Robert V Bruggner; Michael D Linderman; Karen Sachs; Garry P Nolan; Sylvia K Plevritis
Journal:  Nat Biotechnol       Date:  2011-10-02       Impact factor: 54.908

9.  Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells.

Authors:  Merlin Luetke-Eversloh; Quirin Hammer; Pawel Durek; Karl Nordström; Gilles Gasparoni; Matthias Pink; Alf Hamann; Jörn Walter; Hyun-Dong Chang; Jun Dong; Chiara Romagnani
Journal:  PLoS Pathog       Date:  2014-10-16       Impact factor: 6.823

10.  Sustained Immune Complex-Mediated Reduction in CD16 Expression after Vaccination Regulates NK Cell Function.

Authors:  Martin R Goodier; Chiara Lusa; Sam Sherratt; Ana Rodriguez-Galan; Ron Behrens; Eleanor M Riley
Journal:  Front Immunol       Date:  2016-09-26       Impact factor: 7.561

View more
  14 in total

1.  Charge-altering releasable transporters enable phenotypic manipulation of natural killer cells for cancer immunotherapy.

Authors:  Aaron J Wilk; Nancy Lynn-Benner Weidenbacher; Rosemary Vergara; Ole A W Haabeth; Ronald Levy; Robert M Waymouth; Paul A Wender; Catherine A Blish
Journal:  Blood Adv       Date:  2020-09-08

2.  The road ahead: Implementing mass cytometry in clinical studies, one cell at a time.

Authors:  Quentin Baca; Antonio Cosma; Garry Nolan; Brice Gaudilliere
Journal:  Cytometry B Clin Cytom       Date:  2017-01-05       Impact factor: 3.058

Review 3.  Diversification of human NK cells: Lessons from deep profiling.

Authors:  Aaron J Wilk; Catherine A Blish
Journal:  J Leukoc Biol       Date:  2018-01-19       Impact factor: 4.962

4.  Differential Induction of IFN-α and Modulation of CD112 and CD54 Expression Govern the Magnitude of NK Cell IFN-γ Response to Influenza A Viruses.

Authors:  Lisa M Kronstad; Christof Seiler; Rosemary Vergara; Susan P Holmes; Catherine A Blish
Journal:  J Immunol       Date:  2018-08-24       Impact factor: 5.422

5.  IL-15 Promotes Polyfunctional NK Cell Responses to Influenza by Boosting IL-12 Production.

Authors:  Helen R Wagstaffe; Carolyn M Nielsen; Eleanor M Riley; Martin R Goodier
Journal:  J Immunol       Date:  2018-02-28       Impact factor: 5.422

6.  Treated HIV Infection Alters Phenotype but Not HIV-Specific Function of Peripheral Blood Natural Killer Cells.

Authors:  Nancy Q Zhao; Anne-Maud Ferreira; Philip M Grant; Susan Holmes; Catherine A Blish
Journal:  Front Immunol       Date:  2020-05-12       Impact factor: 7.561

7.  Gut Bacteria Induce Granzyme B Expression in Human Colonic ILC3s In Vitro in an IL-15-Dependent Manner.

Authors:  Moriah J Castleman; Stephanie M Dillon; Tezha A Thompson; Mario L Santiago; Martin D McCarter; Edward Barker; Cara C Wilson
Journal:  J Immunol       Date:  2021-06-11       Impact factor: 5.426

8.  Implication of Interleukin-12/15/18 and Ruxolitinib in the Phenotype, Proliferation, and Polyfunctionality of Human Cytokine-Preactivated Natural Killer Cells.

Authors:  Iñigo Terrén; Idoia Mikelez; Irati Odriozola; Andrea Gredilla; Javier González; Ane Orrantia; Joana Vitallé; Olatz Zenarruzabeitia; Francisco Borrego
Journal:  Front Immunol       Date:  2018-04-16       Impact factor: 7.561

9.  BPTF inhibits NK cell activity and the abundance of natural cytotoxicity receptor co-ligands.

Authors:  Kimberly Mayes; Zeinab Elsayed; Aiman Alhazmi; Michael Waters; Suehyb G Alkhatib; Mark Roberts; Carolyn Song; Kristen Peterson; Vivian Chan; Nikhil Ailaney; Pumoli Malapati; Tana Blevins; Berislav Lisnić; Catherine I Dumur; Joseph W Landry
Journal:  Oncotarget       Date:  2017-05-12

10.  Characterization of the Impact of Daclizumab Beta on Circulating Natural Killer Cells by Mass Cytometry.

Authors:  Thanmayi Ranganath; Laura J Simpson; Anne-Maud Ferreira; Christof Seiler; Elena Vendrame; Nancy Zhao; Jason D Fontenot; Susan Holmes; Catherine A Blish
Journal:  Front Immunol       Date:  2020-04-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.